WOIPPY, France, February 19, 2026--(BUSINESS WIRE)--Regulatory News: ABL Diagnostics S.A. (Euronext: ABLD – ISIN: FR001400AHX6) informs the market that the non-binding Letter of Intent entered into ...
ABL Diagnostics S.A. (Euronext: ABLD – ISIN: FR001400AHX6) informs the market that the non-binding Letter of Intent entered into between ProPhase Labs, Inc. and Advanced Biological Laboratories S.A. ( ...
SEOUL, South Korea, Dec. 25, 2025 /PRNewswire/ -- ABL Bio (CEO Sang Hoon Lee), a company specializing in bispecific antibodies, announced that ABL Bio will receive a USD 40 million upfront payment for ...
Asset-Based Lending: How It Works & Where To Get It Your email has been sent Asset-based lending (ABL) helps businesses borrow against receivables, inventory, real estate, and equipment. Learn how ABL ...
Energy and marine consultancy ABL has secured new five-year contracts with long-term client Woodside Energy that expands its existing workscope outside of Australia. ABL has been awarded a global ...
LAFAYETTE, La. — The Affiliated Blind of Louisiana (ABL) will host its 2025 State Convention from Nov. 7–9, combining education, community engagement and fundraising to support services for people who ...
Progress Software Corporation (NASDAQ:PRGS) is one of the most undervalued technology stocks to buy according to analysts. On September 29, Progress Software announced the early customer review and ...
“Generic AI tools struggle with ABL due to limited training data and lack of domain context,” said John Ainsworth, EVP and General Manager, Application and Data Platform, Progress Software. “The ...
Projects using OpenEdge ABL are having their source files skipped by codebase indexing. Adding these extensions to the fallback indexer will include them in search and context, so users can find ...
ALEXANDRIA, Va.--(BUSINESS WIRE)--Oxford Finance LLC (“Oxford” or the “Company”), a leading specialty finance firm, is pleased to announce the appointment of Nick McDearis to lead Asset-Based Lending ...
Abacus Global Management Inc. (NASDAQ:ABL) shares are trading higher Friday after the company announced a $20 million share repurchase program and disclosed insider buying totaling over $2 million.
ABL Bio Inc. announced April 7 that it sealed a potential £2.075 billion (US$2.65 billion) license deal with GSK plc, granting GSK global rights to use ABL’s blood-brain barrier (BBB) penetrating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results